FMA Advisory’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$4.18M Sell
49,257
-1,827
-4% -$153K 1.56% 19
2021
Q2
$4.26M Sell
51,084
-773
-1% -$63.3K 1.58% 19
2021
Q1
$3.9M Sell
51,857
-1,055
-2% -$76.8K 1.2% 22
2020
Q4
$3.61M Sell
52,912
-15
-0% -$976 1.21% 22
2020
Q3
$3.09M Buy
52,927
+424
+0.8% +$26.4K 1.23% 22
2020
Q2
$3.41M Buy
52,503
+2,194
+4% +$138K 1.53% 15
2020
Q1
$2.98M Sell
50,309
-1,334
-3% -$89.1K 1.62% 14
2019
Q4
$3.84M Buy
51,643
+7,964
+18% +$559K 1.54% 17
2019
Q3
$2.75M Buy
43,679
+29,019
+198% +$1.72M 1.2% 23
2019
Q2
$799K Buy
14,660
+928
+7% +$50K 0.35% 80
2019
Q1
$741K Buy
+13,732
New +$848K 0.34% 84
2015
Q2
$413K Buy
+3,936
New +$402K 0.26% 89
2014
Q4
$1.11M Buy
11,530
+863
+8% +$76K 0.39% 97
2014
Q3
$849K Buy
+10,667
New +$841K 0.31% 102
2013
Q4
Sell
-5,311
Closed -$301K 128
2013
Q3
$301K Buy
5,311
+154
+3% +$9.18K 0.12% 146
2013
Q2
$295K Buy
+5,157
New +$299K 0.12% 144

Other funds holding CVS

FMA Advisory's CVS Position: Q3 2021 in Review

FMA Advisory reduced its CVS Health (CVS) stake by 3.6% in Q3 2021, selling an estimated $153K and leaving 49,257 shares worth $4.18M. The position accounts for 1.56% of the portfolio, ranked #19.

FMA Advisory first reported a position in CVS in Q2 2013 and has held it in 16 quarters since. The position peaked at $4.26M in Q2 2021. 2,072 funds tracked by Wall St. Rank hold CVS as of Q3 2021.

  • FMA Advisory held 49,257 shares of CVS Health worth $4.18M as of Q3 2021.
  • FMA Advisory sold 1,827 CVS Health shares in Q3 2021, an estimated $153K.
  • CVS Health made up 1.56% of FMA Advisory's portfolio in Q3 2021, its #19 holding.
  • FMA Advisory first reported a position in CVS Health in Q2 2013 and has held it in 16 quarters since.
  • FMA Advisory's CVS Health position peaked at $4.26M in Q2 2021.
  • 2,072 funds tracked by Wall St. Rank held CVS Health as of Q3 2021.

Based on FMA Advisory's 13F filing for Q3 2021, filed 15 Nov 2021.